discitis: Inflammation of an intervertebral disc or disk space which may lead to disk erosion. Until recently, discitis has been defined as a nonbacterial inflammation and has been attributed to aseptic processes (e.g., chemical reaction to an injected substance). However, recent studies provide evidence that infection may be the initial cause, but perhaps not the promoter, of most cases of discitis. Discitis has been diagnosed in patients following discography, myelography, lumbar puncture, paravertebral injection, and obstetrical epidural anesthesia. Discitis following chemonucleolysis (especially with chymopapain) is attributed to chemical reaction by some and to introduction of microorganisms by others.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
570 |
4. Check minimum number of eventsNone |
570 |
5. Include endpointsNone |
570 |
6. Filter based on genotype QC (FinnGen only) |
570 |
Control definitions (FinnGen only)
- Control exclude
- M13_DORSOPATHY
Extra metadata
- Level in the ICD hierarchy
- 4
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- M46
- Name in latin
- Discitis non specificata
Similar endpoints
↥List of similar endpoints to
Discitis, unspecified
based on the number of shared cases.
Similar with more cases:
- Autoimmune diseases related-to ILD
- Spondylopathies
- Dorsopathies
- Diseases of the musculoskeletal system and connective tissue
- Any operation in hilmo
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 3832 | 1518 | 2294 |
| Only index persons | 3640 | 1453 | 2187 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.06 | 0.04 | 0.06 |
| Only index persons | 0.07 | 0.05 | 0.08 |
| Median age at first event (years) | |||
| Whole population | 64.99 | 67.41 | 63.41 |
| Only index persons | 64.70 | 66.94 | 63.21 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 570 | 218 | 352 |
| Unadjusted period prevalence (%) | 0.12 | 0.07 | 0.16 |
| Median age at first event (years) | 66.27 | 64.83 | 67.16 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 508
- Matched controls
- 5079
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
M46.4
ICD-10 Finland
Discitis, unspecified
+∞
323.0
508
*
NA3CG
NOMESCO Finland
Lumbar spine extensive MRI examination with high intensity magnet
155.7
133.9
137
12
M46.3
ICD-10 Finland
Infection of intervertebral disc (pyogenic)
+∞
118.5
109
*
M54.5
ICD-10 Finland
Low back pain
9.5
106.0
272
550
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
25.1
101.7
147
81
M48.0
ICD-10 Finland
Spinal stenosis
57.1
95.5
112
25
M51.1
ICD-10 Finland
Lumbar and other intervertebral disc disorders with radiculopathy
44.6
79.7
98
27
A41.0
ICD-10 Finland
Sepsis due to Staphylococcus aureus
33.2
78.8
104
39
NA3BG
NOMESCO Finland
Lumbar spine MRI examination with high intensity magnet
30.4
74.8
101
41
N02AX02
ATC
tramadol; systemic, rectal
5.5
70.2
319
1190
A49.9
ICD-10 Finland
Bacterial infection, unspecified
8.0
69.5
180
325
NA3DG
NOMESCO Finland
Lumbar spine very extensive MRI examination with high intensity magnet
265.3
69.1
69
*
J01FF01
ATC
clindamycin; systemic
5.6
66.3
256
776
N03AX16
ATC
pregabalin; oral
6.7
64.5
195
433
N02AA05
ATC
oxycodone; systemic
6.6
60.5
183
401
M54.4
ICD-10 Finland
Lumbago with sciatica
10.2
59.7
127
161
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
8.5
57.9
139
216
ABC36
NOMESCO Finland
Decompression of lumbar nerve roots
612.3
56.8
55
*
M54.9
ICD-10 Finland
Dorsalgia, unspecified
12.1
52.4
100
101
N03AX12
ATC
gabapentin; oral
7.1
48.9
133
243
L03
ICPC
Low back symptom/complaint
5.3
48.2
176
465
M47.2
ICD-10 Finland
Other spondylosis with radiculopathy
246.1
44.7
45
*
FM1BE
NOMESCO Finland
Cardiac ultrasound examination through oesophagus
8.0
44.7
109
168
J01MA12
ATC
levofloxacin; systemic
4.6
44.2
186
563
R50.9
ICD-10 Finland
Fever, unspecified
5.4
44.0
153
377
M51.3
ICD-10 Finland
Other specified intervertebral disc degeneration
34.1
42.4
55
18
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
4.7
41.2
164
463
NA7DG
NOMESCO Finland
Spine and spinal cord very extensive MRI examination with high intensity magnet
57.3
40.3
47
9
N02BE01
ATC
paracetamol; systemic, rectal
6.7
40.1
475
3463
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
3.6
39.8
283
1325
A41.9
ICD-10 Finland
Sepsis, unspecified
10.5
38.6
78
86
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
7.4
38.1
97
157
GD1AA
NOMESCO Finland
Thorax X-ray examination
3.3
36.6
311
1629
M46.9
ICD-10 Finland
Inflammatory spondylopathy, unspecified
+∞
35.8
34
*
G06.1
ICD-10 Finland
Intraspinal abscess and granuloma
+∞
35.8
34
*
C03CA01
ATC
furosemide; systemic
3.4
35.1
239
1050
J04AB02
ATC
rifampicin; systemic
31.4
34.9
46
16
N02AJ06
ATC
codeine and paracetamol; systemic
3.4
34.8
233
1009
TPH30
NOMESCO Finland
Insertion of central venous catheter through periferal vein
27.3
32.9
45
18
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
11.8
31.9
60
57
NA3AD
NOMESCO Finland
Lumbar spine and sacrum CT examination
28.5
31.1
42
16
A02BC02
ATC
pantoprazole; systemic
3.2
30.7
376
2400
NA1BG
NOMESCO Finland
Cervical spine MRI examination with high intensity magnet
17.7
30.0
47
29
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
3.7
29.7
154
531
A40.8
ICD-10 Finland
Other streptococcal sepsis
26.1
29.7
41
17
M46.2
ICD-10 Finland
Osteomyelitis of vertebra
+∞
29.5
28
*
J01CF05
ATC
flucloxacillin; systemic
9.6
28.6
60
70
M03BC01
ATC
orphenadrine (citrate); systemic
3.7
28.2
143
483
J01DB01
ATC
cefalexin; oral
3.8
28.2
443
3267
NA3EA
NOMESCO Finland
Lumbar spine X-ray examination with flexion
106.0
28.0
30
*
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
4.8
27.8
102
254
TPH04
NOMESCO Finland
Cathetrisation of vein
3.4
27.6
166
638
H02AB06
ATC
prednisolone; systemic
2.8
27.6
281
1540
ABC16
NOMESCO Finland
Microsurgical excision of lumbar intervertebral disc displacement
+∞
27.3
26
*
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
4.1
26.9
117
344
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
4.0
26.4
121
372
A46
ICD-10 Finland
Erysipelas
3.7
25.3
128
427
NA7CG
NOMESCO Finland
Spine and spinal cord extensive MRI examination with high intensity magnet
73.7
25.0
28
*
M03BX02
ATC
tizanidine; oral
2.7
24.7
303
1810
J18.9
ICD-10 Finland
Pneumonia, unspecified
3.0
24.7
183
804
M47.82
ICD-10 Finland
Other spondylosis, cervical region
30.9
24.4
32
11
I33.0
ICD-10 Finland
Acute and subacute infective endocarditis
27.0
24.3
33
13
ABC56
NOMESCO Finland
Decompression of lumbar spinal canal and nerve roots
+∞
24.1
23
*
L28
ICPC
Limited function/disability (L)
3.6
23.8
123
415
M54.2
ICD-10 Finland
Cervicalgia
9.3
23.7
50
59
B01AB05
ATC
enoxaparin; parenteral
2.7
22.9
206
1013
A41.8
ICD-10 Finland
Other specified sepsis
14.0
22.8
39
30
NA1CG
NOMESCO Finland
Cervical spine extensive MRI examination with high intensity magnet
30.6
22.1
29
10
JN3BD
NOMESCO Finland
Extensive abdominal CT
4.2
21.7
89
245
WX408
NOMESCO Finland
General anesthesy, balanced
2.8
21.7
179
829
M47.9
ICD-10 Finland
Spondylosis, unspecified
45.5
21.6
26
6
SPAT1255
SPAT
Intravenous administration of medicine
4.9
21.3
73
167
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
4.0
21.2
93
271
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
2.7
21.2
195
959
NAG62
NOMESCO Finland
Posterior fusion of lumbar spine with fixation, 2-3 vertebraea
+∞
21.0
20
*
NK6CT
NOMESCO Finland
Bone biopsy with CT guidance
34.1
20.4
26
8
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
2.6
20.2
184
897
NA2BG
NOMESCO Finland
Thoracal spine MRI examination with high intensity magnet
24.6
20.2
28
12
NA1DG
NOMESCO Finland
Cervical spine very extensive MRI examination with high intensity magnet
+∞
19.9
19
*
NAG40
NOMESCO Finland
Anterior fusion of cervical spine without fixation
+∞
19.9
19
*
ABC26
NOMESCO Finland
Open discectomy of lumbar spine
+∞
19.9
19
*
R4110
NOMESCO Finland
Physiotherapy
2.7
19.8
172
814
I50.9
ICD-10 Finland
Heart failure, unspecified
3.2
19.6
117
435
SPAT1254
SPAT
Administration of medicine
3.3
19.4
111
400
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
3.1
19.2
119
454
JN4BD
NOMESCO Finland
Extensive body CT
3.4
19.2
101
342
S97
ICPC
Chronic ulcer skin
5.0
19.0
63
139
J01MA02
ATC
ciprofloxacin; systemic
2.4
18.8
237
1361
L97
ICD-10 Finland
Ulcer of lower limb, not elsewhere classified
6.8
18.7
48
77
AA1AD
NOMESCO Finland
CT of head and brain
2.7
18.7
159
737
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
2.4
18.7
226
1270
M79.6
ICD-10 Finland
Pain in limb
2.5
18.6
183
921
NA2AA
NOMESCO Finland
Thoracal spine X-ray examination without contrast
12.1
18.3
33
29
A06AD11
ATC
lactulose; oral
3.2
18.2
106
385
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
3.7
18.2
84
255
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
3.0
18.2
117
456
NA2CG
NOMESCO Finland
Thoracal spine extensive MRI examination with high intensity magnet
34.3
18.1
23
7
M46.5
ICD-10 Finland
Other infective spondylopathies
+∞
17.8
17
*
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
2.6
17.6
162
783
A41.5
ICD-10 Finland
Sepsis due to other Gram-negative organisms
6.7
17.4
45
73
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
2.7
17.4
140
625
N06AX21
ATC
duloxetine; oral
4.5
17.3
64
158
UJF32
NOMESCO Finland
Coloscopy
2.5
17.1
165
814
L86
ICPC
Back syndrome with radiating pain
8.9
17.0
36
43
M04AA01
ATC
allopurinol; systemic
3.0
17.0
107
409
S18
ICPC
Laceration/cut
2.3
17.0
248
1506
N17.9
ICD-10 Finland
Acute renal failure, unspecified
5.9
16.9
48
88
M01AH05
ATC
etoricoxib; oral
2.2
16.8
280
1804
NAS20
NOMESCO Finland
Incision and debridement of infection of vertebra, unspecified
+∞
16.8
16
*
WX110
NOMESCO Finland
Local anesthesy
2.3
16.6
348
2485
A01
ICPC
Pain general/multiple sites
4.9
16.5
55
122
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
2.5
16.0
151
733
NF1AE
NOMESCO Finland
Hip joint ultrasound examination
12.8
16.0
28
23
A41.1
ICD-10 Finland
Sepsis due to other specified staphylococcus
34.6
15.8
20
6
NF1AA
NOMESCO Finland
Hip X-ray examination
3.9
15.8
68
194
TPH07
NOMESCO Finland
Cathetrisation of artery
3.2
15.7
88
309
M50.1
ICD-10 Finland
Cervical disc disorder with radiculopathy
27.3
15.7
21
8
M54.8
ICD-10 Finland
Other dorsalgia
14.3
15.7
26
19
Y83
ICD-10 Finland
Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
4.0
15.6
65
180
X59
ICD-10 Finland
Exposure to unspecified factor
2.8
15.5
114
479
M13.9
ICD-10 Finland
Arthritis, unspecified
4.3
15.4
59
151
SPAT1148
SPAT
Treatment of chronic ulcer or burn
2.9
15.0
103
413
JN4AD
NOMESCO Finland
Body CT examination
3.6
15.0
70
213
M43.1
ICD-10 Finland
Spondylolisthesis
21.8
14.8
21
10
N06AA09
ATC
amitriptyline; systemic
3.9
14.7
62
173
NA1AA
NOMESCO Finland
Cervical spine X-ray examination without contrast
11.3
14.7
27
25
M51.9
ICD-10 Finland
Intervertebral disc disorder, unspecified
+∞
14.6
14
*
NA7EA
NOMESCO Finland
Scoliosis X-ray examination
+∞
14.6
14
*
ZXM10
NOMESCO Finland
Intraoperative use of conventional X-ray imaging
5.3
14.5
45
92
JN3AD
NOMESCO Finland
Abdominal CT examination
3.8
14.5
64
186
I10
ICD-10 Finland
Essential (primary) hypertension
2.1
14.5
334
2411
M47.80
ICD-10 Finland
Other spondylosis, multiple sites in spine
17.6
14.4
22
13
L70
ICPC
Infection of musculoskeletal system
28.1
14.4
19
7
NA3SA
NOMESCO Finland
Lumbar spine X-ray examination in standing position
43.8
14.2
17
*
NG1AA
NOMESCO Finland
Knee X-ray examination without contrast
3.2
14.1
79
276
R06.0
ICD-10 Finland
Dyspnoea
2.4
14.1
150
767
B18.2
ICD-10 Finland
Chronic viral hepatitis C
16.3
14.0
22
14
NA3CM
NOMESCO Finland
Lumbar spine extensive MRI examination with 3 Tesla magnet
77.2
13.6
15
*
202
Kela drug reimbursment
Connective tissue diseases, rheumatoid arthritis and comparable disease
3.3
13.6
72
242
M47.1
ICD-10 Finland
Other spondylosis with myelopathy
+∞
13.6
13
*
7227C
ICD-9 Finland
Intervertebral disk disorders, Intervertebral disk disorder with myelopathy[SYNDROMA ISCHIADICUM]
+∞
13.6
13
*
M54
ICD-10 Finland
Dorsalgia
3.5
13.4
65
204
PH1AE
NOMESCO Finland
Ultrasound examination of upper extremity veins
11.9
13.4
24
21
C07AB07
ATC
bisoprolol; oral
2.0
13.4
277
1885
TKC20
NOMESCO Finland
Catheterisation of bladder
3.5
13.4
65
205
M03BC51
ATC
orphenadrine, combinations; systemic
2.3
13.3
139
702
A28
ICPC
Limited function/disability NOS
2.6
13.3
110
491
N18.9
ICD-10 Finland
Chronic kidney disease, unspecified
3.7
13.2
59
173
WX892
NOMESCO Finland
Monitored bed care
3.4
13.2
66
213
TPX10
NOMESCO Finland
Implantation of vascular injection port
6.7
13.1
33
52
TNX10
NOMESCO Finland
Arthrocentesis, unspecified region, unspecified region
4.6
13.1
46
108
SPAT1222
SPAT
Counselling/guidance promoting independent living
2.6
13.1
106
467
M75.1
ICD-10 Finland
Rotator cuff syndrome
2.4
12.6
122
589
72510
ICD-8 Finland
Displacement of intervertebral disk, Lumbalis cum prolapsu disci
+∞
12.5
12
*
NA3DM
NOMESCO Finland
Lumbar spine very extensive MRI examination with 3 Tesla magnet
+∞
12.5
12
*
M54.1
ICD-10 Finland
Radiculopathy
13.6
12.5
21
16
M45
ICD-10 Finland
Ankylosing spondylitis
133.1
12.5
13
*
M46.1
ICD-10 Finland
Sacroiliitis, not elsewhere classified
133.1
12.5
13
*
NAG63
NOMESCO Finland
Posterior fusion of lumbar spine with fixation, more than 3 vertebraea
133.1
12.5
13
*
M10.9
ICD-10 Finland
Gout, unspecified
3.5
12.4
60
188
M17.1
ICD-10 Finland
Other primary gonarthrosis
2.4
12.4
125
617
J01CA04
ATC
amoxicillin; systemic
2.1
12.4
383
3011
I48
ICD-10 Finland
Atrial fibrillation and flutter
2.2
12.3
158
875
K02.1
ICD-10 Finland
Caries of dentine
2.0
12.3
267
1827
M54.6
ICD-10 Finland
Pain in thoracic spine
6.0
12.1
33
58
M54.3
ICD-10 Finland
Sciatica
6.7
12.0
30
47
WYA30
NOMESCO Finland
Preparations for expected poor cooperation
3.6
12.0
55
165
J01CF02
ATC
cloxacillin; systemic
6.4
12.0
31
51
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
2.1
12.0
166
948
B01AA03
ATC
warfarin; systemic
2.2
11.9
147
798
B99
ICD-10 Finland
Other and unspecified infectious diseases
9.3
11.9
24
27
QDB10
NOMESCO Finland
Major dressing of wound of skin of lower limb
4.0
11.8
47
125
SAA03
NOMESCO Finland
Extended examination of mouth
2.0
11.7
183
1094
P19
ICPC
Drug abuse
19.5
11.7
17
9
L17
ICPC
Foot/toe symptom/complaint
2.2
11.5
135
713
G99.2*M47.1
ICD-10 Finland
Spondylogenic compression of spinal cord
+∞
11.5
11
*
TQW11
NOMESCO Finland
Vacuum treatment of wound
7.2
11.5
27
39
C03DA01
ATC
spironolactone; oral
2.8
11.5
78
310
M46.0
ICD-10 Finland
Spinal enthesopathy
122.6
11.5
12
*
M17.0
ICD-10 Finland
Primary gonarthrosis, bilateral
2.6
11.4
89
382
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
2.1
11.4
172
1013
ZX120
NOMESCO Finland
Intravenous
3.0
11.2
68
250
NH3AA
NOMESCO Finland
Foot and toes X-ray examination
3.6
11.2
51
153
N05CF01
ATC
zopiclone; oral
2.0
11.1
173
1030
M00.9
ICD-10 Finland
Pyogenic arthritis, unspecified
11.5
11.1
20
18
M01AB05
ATC
diclofenac; systemic, rectal
1.9
11.1
318
2373
SPAT1217
SPAT
Assessment of need for services (elderly/care support)
3.2
11.0
58
194
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
3.4
11.0
54
172
F11.22
ICD-10 Finland
Addiction-induced dependence is currently independent but uses substitute intermittent medication
44.3
11.0
13
*
207
Kela drug reimbursment
Chronic arrhythmias
2.4
10.9
101
475
NB1AE
NOMESCO Finland
Shoulder ultrasound examination
10.9
10.9
20
19
SPAT1144
SPAT
Treatment of reopened or infected surgical wound
3.2
10.8
57
191
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
2.4
10.8
101
479
J01MA14
ATC
moxifloxacin; systemic
3.1
10.8
62
221
NE1AA
NOMESCO Finland
Pelvis X-ray examination
3.6
10.6
48
143
A07EC01
ATC
sulfasalazine; oral, rectal
3.5
10.6
49
149
N05BA04
ATC
oxazepam; oral
2.2
10.6
127
674
M25.5
ICD-10 Finland
Pain in joint
2.2
10.5
129
692
351
Kela drug reimbursment
Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation
2.5
10.5
89
399
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
1.9
10.5
235
1592
NGB20
NOMESCO Finland
Primary total prosthetic replacement of knee joint without patellar part
2.8
10.5
71
279
NA6BG
NOMESCO Finland
Sacro-iliac joint MRI examination with high intensity magnet
112.2
10.5
11
*
Z01.8
ICD-10 Finland
Other specified special examinations
2.3
10.4
109
544
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
2.0
10.4
160
945
290
Kela drug reimbursment
Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation
2.3
10.2
101
488
XX1AT
NOMESCO Finland
Other puncture with ultrasound guidance
13.5
10.2
17
13
J01XX08
ATC
linezolid; systemic
13.5
10.2
17
13
TK800
NOMESCO Finland
Hemodialysis
6.7
10.1
25
39
R60.0
ICD-10 Finland
Localized oedema
2.7
10.0
72
295
F11.25
ICD-10 Finland
Relationship caused by opiates continuously used
40.9
10.0
12
*
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
4.2
9.9
37
93
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
3.5
9.9
46
141
WX404
NOMESCO Finland
Intravenous generell anesthesy
2.2
9.8
113
587
SPAT1229
SPAT
Assessment of need for aid
3.1
9.8
55
191
Z49.1
ICD-10 Finland
Extracorporeal dialysis
9.8
9.8
19
20
A29
ICPC
General symptom/complaint other
2.8
9.8
67
265
NE1BG
NOMESCO Finland
Pelvic, hip and femur MRI examination with high intensity magnet
7.6
9.8
22
30
SPAT1083
SPAT
Initiation and monitoring of IV fluid therapy
3.9
9.8
40
110
G55.1*M51.1
ICD-10 Finland
Compression of nerve roots and nerve plexus in disc diseases in the lumbar region and other regions
56.1
9.7
11
*
R51.80
ICD-10 Finland
Headache
3.0
9.7
57
207
SPAT1156
SPAT
Guidance concerning treatment of rash and skin
2.4
9.7
84
382
S22.0
ICD-10 Finland
Fracture of thoracic vertebra
8.6
9.6
20
24
G56.0
ICD-10 Finland
Carpal tunnel syndrome
2.8
9.6
64
252
C09AA02
ATC
enalapril; systemic
2.1
9.6
126
695
R60.9
ICD-10 Finland
Oedema, unspecified
4.2
9.5
35
87
M15.9
ICD-10 Finland
Polyarthrosis, unspecified
3.9
9.5
38
102
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
2.5
9.5
80
355
T36
ICD-10 Finland
Poisoning by systemic antibiotics
5.3
9.5
28
55
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
2.6
9.5
70
291
WX290
NOMESCO Finland
Other blockade of nerve
1.9
9.5
194
1261
WZB00
NOMESCO Finland
Telephone receipt or other advice
2.1
9.5
129
719
S32.0
ICD-10 Finland
Fracture of lumbar vertebra
5.8
9.5
26
47
N05BA01
ATC
diazepam; systemic, rectal
2.6
9.4
72
305
F15.2
ICD-10 Finland
Mental and behavioural disorders due to use of other stimulants, including caffeine, dependence syndrome
101.8
9.4
10
*
NAG65
NOMESCO Finland
Anterior and posterior fusion of lumbar spine
+∞
9.4
9
*
ABC60
NOMESCO Finland
Decompression of cervical spinal cord
+∞
9.4
9
*
NA2DG
NOMESCO Finland
Thoracal spine very extensive MRI examination with high intensity magnet
+∞
9.4
9
*
S29
ICPC
Skin symptom/complaint other
2.3
9.4
94
459
N05AH04
ATC
quetiapine; oral
2.5
9.4
77
340
B01AF02
ATC
apixaban; oral
2.6
9.4
71
299
SPAT1216
SPAT
Assessment of functional ability
2.3
9.3
93
452
SPAT1211
SPAT
Application of soft bandage
2.8
9.3
59
225
N06AX11
ATC
mirtazapine; oral
1.9
9.2
156
948
ZXA00
NOMESCO Finland
Right side
1.9
9.1
148
884
TPH90
NOMESCO Finland
Removal of fixed intravenous catheter
8.5
9.1
19
23
ZXM00
NOMESCO Finland
Intraoperative use of ultrasonographic imaging
8.5
9.1
19
23
SPAT1263
SPAT
Sampling
1.8
9.1
208
1401
Z71.8
ICD-10 Finland
Other specified counselling
2.1
9.1
116
631
J45.9
ICD-10 Finland
Asthma, unspecified
2.3
9.1
88
423
M01AC06
ATC
meloxicam; systemic, rectal
1.9
9.1
164
1018
SPAT1149
SPAT
Suture or treatment of traumatic wound
2.4
9.1
80
366
NK4XE
NOMESCO Finland
Joint ultrasound examination not elsewhere classified
3.8
9.0
37
102
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
4.5
9.0
31
73
SPAT1253
SPAT
Initiation, adjustment, discontinuation or repetition of medication
1.9
9.0
154
938
XPX99
NOMESCO Finland
Other diagnostic examination of periferal vessel
3.2
8.9
47
158
E66.2
ICD-10 Finland
Extreme obesity with alveolar hypoventilation
24.5
8.9
12
5
G47.3
ICD-10 Finland
Sleep apnoea
2.1
8.9
111
596
L04AA13
ATC
leflunomide; oral
7.0
8.9
21
31
SPAT1262
SPAT
Handing over of treatment supplies
2.1
8.8
110
589
L99
ICPC
Musculoskeletal disease other
9.7
8.8
17
18
EBA00
NOMESCO Finland
Extraction of tooth
1.9
8.8
165
1037
A02BC05
ATC
esomeprazole; systemic
1.8
8.8
191
1258
K57.3
ICD-10 Finland
Diverticular disease of large intestine without perforation or abscess
2.2
8.7
98
505
N06AB04
ATC
citalopram; systemic
2.1
8.6
103
542
TNX92
NOMESCO Finland
Supporting bandage or orthosis of lower limb
9.2
8.6
17
19
C08CA01
ATC
amlodipine; oral
1.8
8.6
197
1322
M01AH01
ATC
celecoxib; oral (coxibs)
2.3
8.5
84
406
Z50.1
ICD-10 Finland
Other physical therapy
3.7
8.5
36
103
G55.2*M47.9
ICD-10 Finland
Nerve root and plexus compressions in spondylosis
91.5
8.4
9
*
L15
ICPC
Knee symptom/complaint
2.1
8.4
103
548
UKC02
NOMESCO Finland
Cystoscopy
2.1
8.4
101
533
R03AC02
ATC
salbutamol; inhalant
1.7
8.4
235
1675
XX1CT
NOMESCO Finland
Other puncture with CT guidance
+∞
8.4
8
*
ABC30
NOMESCO Finland
Decompression of cervical nerve roots
+∞
8.4
8
*
M48.9
ICD-10 Finland
Spondylopathy, unspecified
+∞
8.4
8
*
M43.0
ICD-10 Finland
Spondylolysis
+∞
8.4
8
*
TAB20
NOMESCO Finland
Epidural puncture
+∞
8.4
8
*
NAW10
NOMESCO Finland
Reoperation for superficial infection in in surgery of spine or neck
+∞
8.4
8
*
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
3.1
8.3
44
149
L03.0
ICD-10 Finland
Cellulitis of finger and toe
3.2
8.3
43
144
EBA15
NOMESCO Finland
Extraction of large number of teeth
3.8
8.2
34
95
205
Kela drug reimbursment
Chronic hypertension
1.8
8.2
167
1076
SFA10
NOMESCO Finland
Fillning on one surface of tooth
1.7
8.1
239
1723
R33
ICD-10 Finland
Retention of urine
2.6
8.1
61
256
NA7BG
NOMESCO Finland
Spine and spinal cord MRI examination with high intensity magnet
33.9
8.1
10
*
M15.0
ICD-10 Finland
Primary generalized (osteo)arthrosis
6.5
8.1
20
32
M80.9
ICD-10 Finland
Unspecified osteoporosis with pathological fracture
10.3
8.1
15
15
L02.4
ICD-10 Finland
Cutaneous abscess, furuncle and carbuncle of limb
4.4
8.0
28
67
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
2.2
7.9
84
420
R05
ICD-10 Finland
Cough
2.1
7.9
94
494
NA1AD
NOMESCO Finland
Cervical spine CT examination
4.6
7.9
26
59
M86.9
ICD-10 Finland
Osteomyelitis, unspecified
8.7
7.9
16
19
R53
ICD-10 Finland
Malaise and fatigue
2.1
7.8
101
546
ZXA05
NOMESCO Finland
Left side
1.9
7.8
133
804
L04AX03
ATC
methotrexate; systemic (immunosuppressants)
2.9
7.8
48
178
A49.8
ICD-10 Finland
Other bacterial infections of unspecified site
15.3
7.7
12
8
M01AB01
ATC
indometacin; systemic, rectal
2.7
7.7
52
204
M53.2
ICD-10 Finland
Spinal instabilities
45.7
7.7
9
*
R02
ICPC
Shortness of breath/dyspnoea
2.4
7.7
67
305
EB1AA
NOMESCO Finland
Tooth X-ray examination
1.7
7.6
251
1857
M50.3
ICD-10 Finland
Other cervical disc degeneration
18.7
7.6
11
6
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
2.7
7.6
51
199
P01AB01
ATC
metronidazole; oral, rectal
1.8
7.6
172
1140
X58
ICD-10 Finland
Exposure to other specified factors
2.4
7.6
66
300
XA402
NOMESCO Finland
ENMG
7.3
7.5
17
24
N03AE01
ATC
clonazepam; systemic
3.6
7.5
32
92
L98.4
ICD-10 Finland
Chronic ulcer of skin, not elsewhere classified
5.7
7.4
20
36
A02BC03
ATC
lansoprazole; oral
1.8
7.4
142
888
A03
ICPC
Fever
2.3
7.4
72
346
N05BA12
ATC
alprazolam; oral
2.6
7.4
53
216
M03BX01
ATC
baclofen; systemic
8.5
7.4
15
18
L03.1
ICD-10 Finland
Cellulitis of other parts of limb
5.1
7.4
22
45
QX2XE
NOMESCO Finland
Ultrsound examination of soft tissue not elsewhere classified
4.6
7.4
24
54
NH1AA
NOMESCO Finland
Ankle X-ray examination without contrast
3.4
7.3
34
105
9211
FHL
Exploration or removal of diskusprolapse
+∞
7.3
7
*
M60.0
ICD-10 Finland
Infective myositis
+∞
7.3
7
*
AB5BT
NOMESCO Finland
Blockage of nerv root with X-ray guidance
+∞
7.3
7
*
J15.9
ICD-10 Finland
Bacterial pneumonia, unspecified
2.6
7.3
54
226
R06.2
ICD-10 Finland
Wheezing
3.7
7.3
30
84
H05BA01
ATC
calcitonin (salmon synthetic); nasal, parenteral
5.6
7.3
20
37
WX002
NOMESCO Finland
Sedation and analgesia
1.9
7.3
108
619
190
Kela drug reimbursment
Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide
16.0
7.3
11
7
R06AE07
ATC
cetirizine; oral
1.7
7.2
182
1240
N06AX16
ATC
venlafaxine; oral
2.4
7.2
59
262
M00.0
ICD-10 Finland
Staphylococcal arthritis and polyarthritis
20.3
7.2
10
5
M05.8
ICD-10 Finland
Other seropositive rheumatoid arthritis
3.2
7.1
35
113
WX872
NOMESCO Finland
Intensive care
2.8
7.1
43
160
L88
ICPC
Rheumatoid/seropositive arthritis
4.4
7.1
24
56
SAA01
NOMESCO Finland
Simple examination of mouth
1.7
7.1
312
2483
E11.8
ICD-10 Finland
Type 2 diabetes mellitus, with unspecified complications
2.3
7.1
65
301
N05CF02
ATC
zolpidem; oral
2.1
7.1
85
448
JN3AA
NOMESCO Finland
Abdominal X-ray examination without contrast
3.4
7.0
33
103
XF400
NOMESCO Finland
ECG with 12 standard connections
2.0
7.0
94
517
A04
ICPC
Weakness/tiredness general
2.2
7.0
68
327
SPAT1301
SPAT
No procedures
1.7
7.0
160
1058
N08.39*E11.2
ICD-10 Finland
Non-insulin-dependent diabetes mellitus - Diabetic nephropathy
6.5
7.0
17
27
R1250
NOMESCO Finland
Evaluation of functional capability
6.5
7.0
17
27
SPAT1260
SPAT
Consultation of another employee
2.0
7.0
92
504
Z76.9
ICD-10 Finland
Person encountering health services in unspecified circumstances
3.2
7.0
35
115
D12.6
ICD-10 Finland
Benign neoplasm: Colon, unspecified
3.2
7.0
35
115
M01AB51
ATC
indometacin, combinations; oral, rectal
6.0
7.0
18
31
N02AJ13
ATC
tramadol and paracetamol; systemic
7.7
6.9
15
20
TK810
NOMESCO Finland
Hemofiltration
14.0
6.9
11
8
L84
ICPC
Back syndrome without radiat pain
3.8
6.9
27
73
M53.1
ICD-10 Finland
Cervicobrachial syndrome
3.0
6.9
37
128
I70.2
ICD-10 Finland
Atherosclerosis of arteries of extremities
2.4
6.8
59
267
E66.00
ICD-10 Finland
Metabolic syndrome
3.3
6.8
32
100
G04CA02
ATC
tamsulosin; oral
1.8
6.8
146
944
SPAT1225
SPAT
Implementation of podiatry rehabilitation plan
4.8
6.8
21
45
K04.5
ICD-10 Finland
Chronic apical periodontitis
1.8
6.8
128
795
M75.4
ICD-10 Finland
Impingement syndrome of shoulder
3.2
6.8
34
112
ZXM20
NOMESCO Finland
Intraoperative use of computerised tomography
40.6
6.8
8
*
I50.1
ICD-10 Finland
Left ventricular failure
3.1
6.8
35
118
B01AB10
ATC
tinzaparin; parenteral
2.7
6.7
46
183
WX000
NOMESCO Finland
Monitoring vital functions without anesthesy
3.6
6.7
28
80
NK6QA
NOMESCO Finland
Measurement of bone density from tow or more locations with X-ray
3.2
6.7
34
113
WW200
NOMESCO Finland
Immunization
4.3
6.7
23
55
NA2AD
NOMESCO Finland
Thoracic spine CT examination
22.8
6.7
9
*
R5599
NOMESCO Finland
Other rehabilitation service
6.6
6.7
16
25
X69
ICD-10 Finland
Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances
6.0
6.7
17
29
S06.0
ICD-10 Finland
Concussion
2.5
6.7
52
223
D50.9
ICD-10 Finland
Iron deficiency anaemia, unspecified
2.5
6.6
49
204
SPAT1137
SPAT
Taking care of patient’s/customer’s hygiene
2.9
6.6
39
143
J22
ICD-10 Finland
Unspecified acute lower respiratory infection
3.6
6.6
28
81
A02BC01
ATC
omeprazole; systemic
1.8
6.6
134
851
Z49.2
ICD-10 Finland
Other dialysis
12.5
6.6
11
9
QDA10
NOMESCO Finland
Incision of skin of lower limb
12.5
6.6
11
9
WX202
NOMESCO Finland
Supraclavicular plexus blockade
8.9
6.6
13
15
M01AX05
ATC
glucosamine; oral
1.9
6.6
101
585
S10
ICPC
Boil/carbuncle
3.2
6.6
33
109
I50.0
ICD-10 Finland
Congestive heart failure
2.5
6.5
51
218
M10.0
ICD-10 Finland
Idiopathic gout
3.6
6.5
27
77
KA1AE
NOMESCO Finland
Kidney ultrasound examination
3.9
6.5
25
67
P01BA02
ATC
hydroxychloroquine; oral
2.7
6.4
42
164
NA3BD
NOMESCO Finland
Extensive lumbar spine and sacrum CT examination
70.7
6.4
7
*
NAU20
NOMESCO Finland
Removal of internal fixation device from spine or neck
70.7
6.4
7
*
E66.8
ICD-10 Finland
Other obesity
3.5
6.4
28
83
L01
ICPC
Neck symptom/complaint
2.3
6.4
59
276
C09BA02
ATC
enalapril and diuretics; systemic
2.4
6.4
54
242
SPAT1265
SPAT
Breathalyser
8.3
6.4
13
16
J01CF01
ATC
dicloxacillin; systemic
8.3
6.4
13
16
T84.0
ICD-10 Finland
Mechanical complication of internal joint prosthesis
3.9
6.4
24
63
SFA20
NOMESCO Finland
Filling on two surfaces of tooth
1.6
6.3
247
1881
E11.2
ICD-10 Finland
Type 2 diabetes mellitus, with renal complications
3.5
6.3
28
84
ACC51
NOMESCO Finland
Release of median nerve
2.9
6.3
36
129
M54.0
ICD-10 Finland
Panniculitis affecting regions of neck and back
18.3
6.3
9
5
F19.29
ICD-10 Finland
Addiction caused by several drugs in combination and by other psychoactive substances UNS
18.3
6.3
9
5
SAA02
NOMESCO Finland
Basic examination of mouth
1.6
6.3
267
2078
NA7DM
NOMESCO Finland
Spine and spinal cord very extensive MRI examination with 3 Tesla magnet
+∞
6.3
6
*
M46.8
ICD-10 Finland
Other specified inflammatory spondylopathies
+∞
6.3
6
*
72880
ICD-8 Finland
Vertebrogenic pain syndrome, Radicula syndrome of lower limbs
+∞
6.3
6
*
NA3BA
NOMESCO Finland
Lumbar spine extensive X-ray examination without contrast
+∞
6.3
6
*
XF600
NOMESCO Finland
Bloodpressure measurement
2.8
6.2
38
143
A40.1
ICD-10 Finland
Sepsis due to streptococcus, group B
27.0
6.2
8
*
F13.22
ICD-10 Finland
Addiction relationship caused by sedatives and hypnotics currently independent but uses substitute intermittent medication
27.0
6.2
8
*
NH1AE
NOMESCO Finland
Ankle joint ultrasound examination
27.0
6.2
8
*
M19.0
ICD-10 Finland
Primary arthrosis of other joints
2.5
6.2
45
187
M02AA07
ATC
piroxicam; topical
1.7
6.2
169
1166
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
3.0
6.2
35
123
M05BA04
ATC
alendronic acid; oral
2.6
6.2
44
181
M01AE03
ATC
ketoprofen; systemic, rectal
1.7
6.2
175
1221
QDB05
NOMESCO Finland
Revision of wound of skin of lower limb
4.0
6.2
23
60
R52.0
ICD-10 Finland
Acute pain
4.8
6.2
19
41
E11.7
ICD-10 Finland
Type 2 diabetes mellitus, with multiple complications
2.7
6.1
40
156
SFA30
NOMESCO Finland
Filling on tree or more surfaces of tooth
1.6
6.1
181
1280
M01AE01
ATC
ibuprofen; systemic, rectal
1.7
6.1
412
3609
B03XA03
ATC
methoxy polyethylene glycol-epoetin beta; parenteral
12.7
6.1
10
8
WX402
NOMESCO Finland
General anaesthesia
2.0
6.1
74
392
S19
ICPC
Skin injury other
3.6
6.1
25
71
A40.3
ICD-10 Finland
Sepsis due to Streptococcus pneumoniae
8.7
6.1
12
14
138
Kela drug reimbursment
Severe anaemia associated with chronic renal failure
4.2
6.1
21
51
Z01.2
ICD-10 Finland
Dental examination
1.7
6.1
169
1175
NGF00
NOMESCO Finland
Excision of plica of synovy of knee
5.3
6.1
17
33
D07AC01
ATC
betamethasone; topical
1.7
6.1
165
1140
T81.0
ICD-10 Finland
Haemorrhage and haematoma complicating a procedure, not elsewhere classified
2.8
6.0
37
140
127
Kela drug reimbursment
Transplant complication
6.1
6.0
15
25
T84.5
ICD-10 Finland
Infection and inflammatory reaction due to internal joint prosthesis
5.7
6.0
16
29
F32.10
ICD-10 Finland
Moderate depressive episode without somatic syndrome
3.2
6.0
30
99
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3023368) Bacteria identified in Blood by Culture
404
1307
8.18
131.33
10.7
4.3
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
111
79
17.21
125.42
1.6
1.6
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
265
626
7.04
117.21
2.8
2.1
—
—
—
0
0
(3001604) Monocytes [#/volume] in Blood
430
2109
5.23
70.00
12.5
5.5
e9/l
0.7
0.6
4.58
396
1807
(3006315) Basophils [#/volume] in Blood
431
2119
5.24
69.90
12.7
5.5
e9/l
0.0
0.0
1.06
399
1826
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
91
116
9.15
68.79
2.5
1.5
—
—
—
0
0
(3019198) Lymphocytes [#/volume] in Blood
432
2161
5.13
67.57
12.7
5.6
e9/l
1.7
1.9
1.99
401
1889
(3013115) Eosinophils [#/volume] in Blood
433
2187
5.08
66.39
13.0
5.7
e9/l
0.2
0.2
1.96
403
1908
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
45
17
28.65
65.98
1.2
1.0
iu/ml
288.3
287.8
0.00
45
17
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
111
194
6.86
63.37
2.6
1.9
ug/l
4.6
3.0
0.19
105
174
(3006504) Eosinophils/100 leukocytes in Blood
406
2003
4.57
62.93
13.2
5.6
%
3.0
2.8
0.87
397
1866
(42870588) Differential panel, method unspecified - Blood
333
1429
4.20
62.91
11.9
5.6
—
—
—
0
0
(3019069) Monocytes/100 leukocytes in Blood
407
2013
4.57
62.83
13.6
5.9
%
9.0
9.0
0.00
397
1887
(3022096) Basophils/100 leukocytes in Blood
396
1947
4.39
60.95
12.9
5.7
%
0.6
0.6
0.02
386
1818
(3002030) Lymphocytes/100 leukocytes in Blood
406
2052
4.40
59.58
13.2
5.8
%
23.5
26.6
6.93
394
1905
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
137
316
5.39
58.11
2.2
1.5
—
—
—
0
0
(3018010) Neutrophils/100 leukocytes in Blood
398
2018
4.22
57.28
13.0
5.6
%
60.8
58.1
4.43
386
1895
(3013650) Neutrophils [#/volume] in Blood by Automated count
446
2477
4.68
55.72
17.3
9.2
e9/l
4.6
4.2
3.31
412
2157
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
90
146
7.13
54.86
2.9
2.5
u/ml
0.3
0.4
1.28
58
85
(3003458) Phosphate [Moles/volume] in Serum or Plasma
190
611
4.16
52.49
10.0
6.3
mmol/l
1.1
1.0
2.30
182
565
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
422
2338
4.10
50.77
9.9
6.5
umol/l
10.9
12.2
1.91
413
2217
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
408
2234
3.91
49.39
13.8
6.9
mmol/l
1.2
1.2
1.17
363
1860
(3020779) Urea [Moles/volume] in Serum or Plasma
153
440
4.39
48.84
13.6
7.4
mmol/l
13.1
10.6
2.92
146
415
(3004588) Protein electrophoresis panel - Serum or Plasma
127
316
4.88
48.72
2.8
2.3
—
—
—
0
0
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
186
621
3.96
48.26
3.9
2.6
%
18.7
22.5
3.41
171
535
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
210
770
3.73
47.34
2.5
1.8
—
—
—
0
0
(3004789) Transferrin [Mass/volume] in Serum or Plasma
191
659
3.86
47.11
4.0
2.5
g/l
2.1
2.3
3.19
179
614
(3020630) Protein [Mass/volume] in Serum or Plasma
138
384
4.42
45.77
2.9
2.6
g/l
65.6
65.9
0.18
133
355
(3022948) Iron [Moles/volume] in Serum or Plasma
198
715
3.71
45.41
4.0
2.5
umol/l
10.1
12.8
5.54
188
663
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
260
1132
3.38
44.14
2.8
2.1
mg/l
3.4
3.1
0.82
231
948
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
372
2042
3.37
42.15
12.3
5.9
mmol/l
1.2
1.2
1.80
360
1840
(3024561) Albumin [Mass/volume] in Serum or Plasma
361
1957
3.30
41.58
7.9
4.8
g/l
31.6
35.2
18.21
345
1819
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
74
132
6.29
40.80
1.5
1.6
iu/ml
0.2
0.1
0.13
28
21
(3032080) INR in Blood by Coagulation assay
359
1958
3.25
40.56
15.5
10.4
inr
1.4
1.3
0.82
107
585
(3012095) Magnesium [Moles/volume] in Serum or Plasma
195
749
3.44
39.93
4.6
3.4
mmol/l
0.8
0.8
1.10
185
708
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
86
184
5.33
39.00
2.5
3.1
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
316
1640
3.08
38.23
4.8
3.1
—
—
—
0
0
(3031040) Bacteria [#/volume] in Urine by Automated count
448
2853
3.66
37.74
7.0
4.1
e6/l
1644.8
3358.4
—
5
49
(46235355) HIV 1 and 2 tests - Meaningful Use set
155
537
3.59
37.01
2.1
1.7
—
—
—
0
0
(3034860) Kappa light chains.free [Mass/volume] in Serum
75
149
5.64
36.86
3.3
3.4
mg/l
54.1
111.2
0.72
56
119
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
75
149
5.64
36.86
3.3
3.4
mg/l
33.8
53.5
0.48
56
122
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
74
146
5.68
36.63
3.3
3.4
ratio
1.7
1.2
—
7
12
(3026493) Urate [Moles/volume] in Serum or Plasma
249
1155
3.05
36.43
4.4
2.7
umol/l
5358.4
7296.8
0.25
214
1000
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
497
3421
4.54
36.40
17.3
7.5
u/l
93.7
79.3
8.64
482
3188
(3026008) Bacteria identified in Urine by Culture
263
1266
3.00
35.87
4.8
2.9
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
50
67
8.08
35.77
1.6
1.5
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
64
113
6.25
35.53
1.4
1.5
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
475
3196
3.92
35.42
8.8
3.7
mm/h
26.7
13.1
22.57
460
2888
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
69
132
5.81
35.27
1.4
1.2
—
—
—
0
0
(3021447) Carbon dioxide [Partial pressure] in Venous blood
133
430
3.73
35.10
7.1
3.7
kpa
5.8
5.8
0.15
127
415
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
269
1330
2.94
34.64
3.3
2.5
u/l
50.9
58.0
3.29
261
1230
(3002032) Base excess in Venous blood by calculation
132
429
3.70
34.53
7.1
3.7
mmol/l
1.5
2.0
0.52
113
340
(3030467) Casts [#/volume] in Urine by Automated count
258
1254
2.93
34.19
4.3
3.1
e6/l
0.7
0.5
0.38
215
956
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
96
253
4.36
33.61
1.6
1.4
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
301
1599
2.87
33.58
5.1
3.5
e6/l
113.9
170.3
0.46
239
1153
(3013826) Glucose [Moles/volume] in Serum or Plasma
421
2678
3.19
33.47
9.5
4.7
mmol/l
6.9
6.8
0.21
413
2522
(3007853) Bacteria identified in Skin by Aerobe culture
145
513
3.45
33.18
2.8
1.6
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
274
1395
2.86
33.00
4.4
3.1
e6/l
44.6
123.1
0.97
229
1083
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
262
1306
2.86
32.80
2.8
2.0
u/l
389.1
305.4
0.18
250
1219
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
147
531
3.38
32.47
2.3
1.8
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
61
113
5.93
32.19
2.9
3.8
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
147
534
3.36
32.15
2.2
1.8
—
—
—
0
0
(3018418) pH of Serum or Plasma
262
1319
2.83
32.00
8.7
4.1
ph
7.4
7.4
0.26
54
268
(3037467) Urinalysis macro (dipstick) panel - Urine
446
2977
3.29
31.67
7.1
4.0
—
—
—
0
0
(40758558) Short blood count panel - Blood
229
1080
2.87
31.59
14.0
6.7
—
—
—
0
0
(3000991) Gas panel - Venous blood
119
384
3.65
31.25
12.4
8.9
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
314
1751
2.77
31.18
4.3
2.7
ug/l
187.8
151.1
1.86
296
1586
(36304419) Bacteria [Presence] in Urine
244
1198
2.81
31.07
4.2
3.0
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
275
1445
2.75
30.55
5.1
3.2
ng/l
2726.6
1653.0
1.81
253
1265
(3027945) Reticulocytes/100 erythrocytes in Blood
146
548
3.24
30.08
2.9
2.6
%
1.8
1.8
0.18
135
490
(3022217) INR in Platelet poor plasma by Coagulation assay
157
618
3.13
29.80
34.0
26.5
inr
1.5
1.4
0.31
16
86
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
144
541
3.22
29.57
5.6
4.2
u/l
226.9
243.0
1.07
138
512
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
339
2013
2.69
28.95
5.6
3.9
—
—
—
0
0
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
85
228
4.21
28.91
1.4
2.0
g/l
1.8
1.6
0.71
77
200
(3044640) Blood type and Crossmatch panel - Blood
264
1401
2.65
28.17
3.4
2.4
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
329
1947
2.63
27.94
22.8
9.7
e9/l
0.0
0.0
0.45
283
1596
(3027801) Oxygen [Partial pressure] in Arterial blood
139
532
3.13
27.48
9.7
7.3
kpa
11.6
12.1
0.65
130
515
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
139
532
3.13
27.48
9.7
7.4
kpa
5.3
5.1
1.13
130
517
(3037756) Immunofixation for Serum or Plasma
55
107
5.58
27.48
1.3
1.7
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
131
487
3.19
27.19
1.5
1.3
titre
308.2
360.4
0.32
34
96
(3000475) Leukocytes [#/volume] in Synovial fluid
51
94
5.86
26.97
1.6
1.5
e6/l
53726.3
25625.3
0.44
33
68
(3000494) Fungus identified in Specimen by Culture
135
518
3.10
26.49
1.6
1.4
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
138
539
3.06
26.23
9.9
7.3
mmol/l
1.3
1.3
0.05
116
429
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
259
1398
2.56
26.21
4.8
3.2
u/l
35.8
33.6
0.43
249
1331
(3016502) Oxygen saturation in Arterial blood
129
488
3.12
25.89
10.3
7.8
%
95.9
95.4
0.55
123
475
(3000850) Epithelial cells [#/volume] in Urine
199
952
2.68
25.76
3.5
2.5
e6/l
5.4
5.4
0.01
180
839
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
290
1660
2.52
25.76
2.9
2.2
nmol/l
74.7
77.4
0.79
268
1456
(3023520) Reticulocytes [#/volume] in Blood
115
413
3.24
25.15
3.1
2.8
e9/l
67.5
68.4
0.09
84
316
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
50
100
5.38
24.20
1.7
1.3
—
—
—
0
0
(3005719) IgG [Mass/volume] in Serum or Plasma
100
339
3.36
23.97
3.1
2.9
g/l
11.2
10.7
0.39
92
313
(3024354) Oxygen [Partial pressure] in Venous blood
104
362
3.29
23.88
7.0
2.8
kpa
5.1
4.4
1.75
98
349
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
208
1051
2.54
23.72
3.1
2.4
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
37
56
7.00
23.67
1.7
1.3
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
332
2077
2.43
23.53
5.7
3.3
estimate
0.0
0.0
0.00
74
392
(3021960) Folate [Moles/volume] in Serum or Plasma
217
1127
2.49
23.24
1.7
1.5
nmol/l
18.2
21.0
1.52
200
931
(3026782) Osmolality of Urine
189
925
2.56
22.93
3.9
2.7
mosm/kgh2o
507.7
569.5
4.04
172
795
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
162
738
2.67
22.74
3.3
2.8
e6/l
1.5
1.2
0.35
101
428
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
179
858
2.58
22.64
3.2
1.6
mg/l
1.4
1.5
0.32
151
673
(3019309) Folate [Moles/volume] in Red Blood Cells
183
890
2.56
22.42
2.3
1.8
nmol/l
1260.8
1141.4
0.76
148
676
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
65
173
4.11
22.18
3.6
2.0
—
—
—
0
0
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
65
173
4.11
22.18
3.6
2.0
g/l
8.4
7.2
3.32
50
127
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
65
173
4.11
22.18
3.6
2.0
g/l
4.1
3.6
2.09
50
121
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
293
1766
2.36
22.17
6.3
3.6
ng/l
45.3
66.0
0.54
242
1314
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
157
719
2.63
21.69
3.5
2.9
e6/l
2.9
1.8
0.87
96
409
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
87
287
3.40
21.68
5.0
3.9
mmol/l
2.3
2.2
0.04
65
220
(3009261) Glucose [Presence] in Urine by Test strip
328
2093
2.34
21.49
5.8
3.4
estimate
0.0
0.0
0.50
75
383
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
61
160
4.15
21.21
3.6
2.0
g/l
11.1
10.3
0.41
55
137
(3021601) Nitrite [Presence] in Urine by Test strip
325
2082
2.31
20.87
7.6
4.6
estimate
0.0
0.0
0.00
77
402
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
537
4382
4.89
20.86
49.1
14.3
mg/l
36.3
27.3
7.15
513
3478
(3009343) pH of Capillary blood
89
305
3.27
20.83
5.2
3.8
ph
7.4
7.4
0.49
14
38
(3028707) Methadone [Presence] in Urine by Screen method
26
30
9.03
20.80
11.0
3.3
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
119
484
2.84
20.63
3.2
2.7
umol/l
11.2
9.3
0.34
106
433
(3023183) Ammonium ion [Moles/volume] in Plasma
46
99
4.97
20.45
2.5
2.9
umol/l
31.9
35.7
0.71
41
86
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
60
160
4.07
20.39
3.8
2.0
g/l
3.7
3.2
2.25
50
125
(3017143) Hepatitis C virus Ab [Presence] in Serum
106
413
2.92
19.84
2.1
1.6
—
—
—
0
0
(1616796) Gas panel - Central venous blood
46
103
4.77
19.51
5.5
4.0
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
127
552
2.67
19.27
1.3
1.2
u/ml
9.5
16.9
0.59
43
196
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
44
97
4.83
19.01
7.5
5.8
iu/ml
958.8
310.1
—
9
14
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
298
1894
2.20
18.84
2.3
2.0
pmol/l
95.1
94.2
0.14
180
983
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
90
332
3.03
18.51
5.4
4.1
ng/l
140.6
88.9
2.72
81
284
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
130
592
2.55
17.82
1.5
1.2
iu/ml
48.5
43.9
0.09
54
189
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
29
46
6.59
17.71
1.6
1.5
%
75.8
67.5
0.55
23
33
(3002179) Metamyelocytes/100 leukocytes in Blood
87
324
2.99
17.56
4.5
4.2
%
0.6
0.5
0.24
27
88
(3011288) Drugs identified in Urine by Screen method
31
54
6.01
17.29
9.9
3.5
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
92
357
2.88
17.23
4.5
4.3
%
0.9
0.9
0.08
35
112
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
105
438
2.71
17.14
2.4
2.0
g/l
0.2
0.2
2.12
95
409
(40767503) Oxygen content in Capillary blood by calculation
41
93
4.67
17.11
3.4
2.7
%
14.4
16.4
1.67
24
49
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
114
497
2.62
17.04
7.8
3.2
—
—
—
0
0
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
98
406
2.71
16.17
2.5
2.2
u/l
28.2
143.4
0.51
82
358
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
98
409
2.69
15.92
3.0
2.2
ug/l
9.3
7.6
0.36
84
359
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
34
70
5.10
15.88
1.1
1.3
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
87
342
2.82
15.86
4.4
4.4
%
0.1
0.1
0.34
33
106
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
106
461
2.60
15.85
2.2
1.6
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
29
52
5.82
15.70
1.1
1.2
—
—
—
0
0
(3036481) Cortisol [Moles/volume] in Serum or Plasma
86
343
2.78
15.23
2.1
2.3
nmol/l
375.3
382.5
0.10
81
318
(3019060) Gas panel - Arterial blood
79
303
2.87
15.04
6.9
4.0
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
33
70
4.94
14.89
5.8
3.8
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
19
23
8.51
14.58
2.6
1.6
—
—
—
0
0
(3004119) Hemoglobin [Mass/volume] in Venous blood
77
300
2.81
14.22
6.9
3.0
g/l
118.1
126.8
2.67
77
292
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
77
302
2.79
14.04
2.3
1.5
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
80
321
2.74
13.96
4.3
4.5
%
0.0
1.1
0.57
28
92
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
68
250
2.95
13.96
13.8
9.8
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
44
123
3.79
13.96
1.6
1.7
—
—
—
0
0
(3012501) Base excess in Blood by calculation
40
106
3.98
13.66
8.6
3.7
mmol/l
2.6
2.4
0.18
32
70
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
67
249
2.92
13.48
11.7
10.4
mmol/l
24.6
24.6
0.05
62
236
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
326
2317
1.95
13.47
3.0
2.6
—
—
—
0
0
(3010421) pH of Blood
45
131
3.64
13.46
9.7
3.6
ph
7.4
7.4
0.59
38
103
(1001926) Buprenorphine [Presence] in Urine by Screen method
29
60
5.04
13.46
10.4
2.2
—
—
—
0
0
(3030905) Polymorphonuclear cells [#/volume] in Blood
33
77
4.49
13.29
3.7
2.6
e9/l
4.7
4.6
0.05
33
77
(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma
18
23
8.05
13.22
1.3
1.3
u/l
43.0
21.0
0.92
18
18
(3021879) Hepatitis B virus core Ab [Presence] in Serum
70
271
2.80
13.06
1.7
1.6
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
38
101
3.96
12.93
4.3
2.7
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
162
918
2.07
12.76
5.4
3.3
—
—
—
0
0
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
43
126
3.61
12.74
3.4
3.0
mg/l
2.2
1.7
1.96
36
114
(3023103) Potassium [Moles/volume] in Serum or Plasma
537
4690
3.50
12.33
50.8
17.2
mmol/l
4.0
4.0
1.17
530
4545
(3019550) Sodium [Moles/volume] in Serum or Plasma
536
4679
3.44
12.26
50.2
17.1
mmol/l
138.8
139.7
11.40
529
4538
(40760892) CBC W Ordered Manual Differential panel - Blood
157
891
2.05
12.25
7.3
4.6
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
52
177
3.13
12.17
3.8
3.3
g/l
0.5
0.2
0.87
34
73
(21494890) Protein electrophoresis panel - 24 hour Urine
24
46
5.40
12.11
1.5
2.6
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
33
83
4.16
12.08
4.7
3.0
%
61.6
58.2
0.86
33
83
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
30
70
4.47
12.08
1.5
1.5
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
157
895
2.04
12.08
4.8
3.6
ng/l
1154.9
326.7
1.15
134
735
(4198724)
17
8
21.85
12.07
1.8
1.1
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
40
117
3.60
11.88
1.7
1.8
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
30
72
4.34
11.67
11.4
2.1
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
230
1522
1.86
11.21
4.3
3.5
mmol/l
2.3
2.4
1.02
200
1319
(3034891) Synovial lining cells/100 cells in Synovial fluid
14
16
8.95
11.16
1.2
1.2
%
2.9
1.0
—
7
5
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
403
3175
1.92
11.14
4.1
3.6
pmol/l
14.8
15.0
0.41
368
2830
(3000764) Benzodiazepines [Presence] in Urine
31
80
4.04
10.98
11.2
2.0
—
—
—
0
0
(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood
57
217
2.81
10.95
10.4
3.7
%
54.9
47.1
1.31
57
211
(3027008) Opiates [Presence] in Urine
31
81
3.99
10.80
11.1
2.0
—
—
—
0
0
(3010144) Erythrocytes [#/volume] in Synovial fluid
20
37
5.57
10.47
1.5
1.3
e6/l
12221.7
122525.9
0.61
12
22
(3021901) Oxygen saturation in Capillary blood
32
89
3.75
10.23
3.7
3.0
—
—
—
0
0
(3020891) Body temperature
48
173
2.94
10.18
11.6
3.7
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
166
1018
1.89
10.08
2.0
1.7
pmol/l
461.3
27778204.1
1.01
138
810
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
32
90
3.71
10.07
1.7
1.9
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
238
1633
1.79
10.01
6.6
3.5
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
30
81
3.85
10.00
12.2
1.5
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
30
81
3.85
10.00
1.6
1.7
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
30
81
3.85
10.00
11.7
2.0
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
39
126
3.25
9.95
1.2
1.7
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
536
4773
3.06
9.94
23.6
10.2
u/l
27.0
26.1
0.50
522
4566
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
27
68
4.12
9.88
1.8
1.8
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
53
205
2.75
9.88
1.3
1.2
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
524
4619
2.67
9.81
38.3
13.8
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
361
2808
1.78
9.70
5.5
2.9
u/l
75.9
54.1
3.37
347
2578
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
17
29
6.01
9.64
1.2
1.4
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
439
3628
1.91
9.61
48.3
17.8
%
14.5
13.7
17.93
432
3546
(3009508) Creatinine [Moles/volume] in Urine
223
1517
1.77
9.55
5.2
3.2
mmol/l
7.0
7.6
1.05
194
1249
(3004809) Band form neutrophils/100 leukocytes in Blood
28
75
3.87
9.44
2.6
2.9
%
0.8
1.3
0.33
23
58
(3003434) Protein [Mass/volume] in Pleural fluid
26
66
4.08
9.42
1.2
1.5
g/l
35.5
29.0
1.44
20
59
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
49
187
2.77
9.37
2.6
1.6
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
25
62
4.17
9.33
1.6
1.8
—
—
—
0
0
(3027456) Digoxin [Moles/volume] in Serum or Plasma
37
122
3.17
9.14
3.0
3.2
nmol/l
0.8
0.9
0.29
32
99
(3007164) IgA [Mass/volume] in Serum or Plasma
125
721
1.94
9.03
2.0
1.5
g/l
3.4
2.5
2.60
90
436
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
32
97
3.44
9.03
1.3
1.3
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
32
97
3.44
9.03
1.3
1.3
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
176
1134
1.80
8.96
7.1
3.5
estimate
0.0
0.0
0.69
65
380
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
27
74
3.78
8.82
1.6
1.7
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
50
200
2.64
8.73
3.1
1.7
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
34
110
3.22
8.67
1.4
1.4
—
—
—
0
0
(3022313) Gas panel - Capillary blood
54
226
2.53
8.61
6.4
3.8
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
33
106
3.24
8.51
1.4
1.2
—
—
—
0
0
(3024263) Appearance of Synovial fluid
13
19
6.98
8.47
1.5
1.3
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
24
63
3.93
8.32
1.1
1.0
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
26
73
3.68
8.22
2.9
2.3
—
—
—
0
0
(3047189) Immunofixation for 24 hour Urine
14
23
6.22
8.21
1.1
1.8
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
20
46
4.47
8.21
3.0
4.1
—
—
—
0
0
(3026361) Erythrocytes [#/volume] in Blood
544
4960
3.12
8.14
60.8
21.0
e12/l
4.2
4.5
34.64
538
4777
(3010813) Leukocytes [#/volume] in Blood
544
4960
3.12
8.14
60.8
21.0
e9/l
7.4
6.7
7.87
537
4778
(3006184) Hemoglobin [Mass/volume] in Capillary blood
31
99
3.25
8.07
2.3
2.4
g/l
115.3
130.4
1.81
25
78
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
27
79
3.54
8.04
1.4
1.1
—
—
—
0
0
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
11
14
7.99
8.01
1.9
3.2
—
—
—
0
0
(3007461) Platelets [#/volume] in Blood
543
4958
3.01
7.87
61.0
21.0
e9/l
253.2
240.0
3.76
535
4797
(40768797) Stomach Pathology biopsy report
99
552
1.96
7.83
1.2
1.2
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
25
71
3.64
7.78
1.3
1.2
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
461
3965
1.85
7.68
5.2
4.4
mu/l
2.4
2.0
0.41
433
3528
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
30
97
3.21
7.67
1.5
1.4
—
—
—
0
0
(3044889) 12 lead EKG panel
394
3248
1.69
7.56
5.5
3.9
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
20
50
4.11
7.40
1.4
1.8
—
—
—
0
0
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
25
74
3.49
7.33
1.5
1.1
u/ml
291.3
322.1
0.19
15
43
(3012516) Albumin [Mass/volume] in Urine
207
1464
1.65
7.23
4.1
3.3
mg/l
751.9
181.8
0.87
155
954
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
24
70
3.54
7.19
1.6
1.7
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
217
1558
1.63
7.12
4.8
4.1
mg/mmol
21.5
8.0
2.19
155
1013
(3016650) Hepatitis A virus Ab [Presence] in Serum
23
66
3.59
7.06
1.1
1.0
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
20
52
3.95
7.04
1.3
1.3
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
67
337
2.12
7.00
3.7
2.9
ml/min/173m2
44.1
58.5
2.16
32
135
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
82
447
1.97
6.89
2.6
1.9
%
1.6
1.5
0.39
69
387
(3045788) Cell count panel - Pleural fluid
18
44
4.19
6.86
1.5
1.4
—
—
—
0
0
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
41
169
2.54
6.76
1.5
2.1
u/l
32.6
36.7
0.61
35
151
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
77
414
1.99
6.72
5.3
3.1
ng/l
329.3
236.1
0.75
71
380
(3041096) Erythrocytes [Presence] in Urine by Automated
171
1172
1.66
6.66
5.7
3.1
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
455
3966
1.73
6.39
42.6
15.5
%
37.5
39.7
5.86
299
2677
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
482
4272
1.83
6.38
36.8
13.8
ml/min/173m2
72.4
77.0
3.43
438
3533
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
16
38
4.30
6.32
2.1
2.1
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
138
906
1.69
6.29
6.6
3.6
kg/l
1.0
1.0
0.58
15
129
(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing
9
5
18.25
6.28
1.2
1.0
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
33
129
2.65
6.07
4.9
3.3
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
12
23
5.31
6.03
1.5
1.4
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
12
23
5.31
6.03
1.5
1.4
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
18
49
3.76
5.96
1.3
1.6
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
18
49
3.76
5.96
1.4
1.8
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
18
49
3.76
5.96
1.3
1.6
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
18
49
3.76
5.96
1.3
1.6
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
22
69
3.28
5.93
1.9
1.2
—
—
—
0
0
(3019230) Fractional oxyhemoglobin in Venous blood
25
86
2.99
5.80
4.2
2.2
%
55.7
62.9
0.68
25
86
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
14
32
4.46
5.79
1.0
1.2
—
—
—
0
0
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
21
65
3.32
5.78
2.1
2.4
pg
30.0
33.0
1.55
21
65
(3008898) HLA-B27 [Presence]
27
98
2.84
5.71
1.1
1.1
—
—
—
0
0
(3028308) Erythrocytes [#/volume] in Pleural fluid
17
46
3.78
5.68
1.3
1.3
e6/l
54167.3
28583.5
—
9
26
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
10
17
5.97
5.64
2.6
1.2
—
—
—
0
0
(3023199) Leukocytes [#/volume] in Pleural fluid
19
56
3.48
5.63
1.3
1.3
e6/l
64642.2
1336.5
0.49
11
39
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
13
29
4.56
5.53
1.5
1.4
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
13
29
4.56
5.53
1.5
1.4
—
—
—
0
0
(3017704) Immunofixation for Urine
13
29
4.56
5.53
1.3
2.3
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
17
47
3.70
5.52
2.9
2.7
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
19
57
3.41
5.49
1.9
1.9
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
25
89
2.89
5.47
1.4
1.5
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
474
4235
1.71
5.40
7.3
6.0
mmol/mol
41.7
40.5
1.57
448
3872
(40761535) Cells panel - Urine sediment
65
356
1.93
5.38
6.6
3.1
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
127
849
1.64
5.33
4.2
3.2
mmol/l
2.5
2.5
1.35
107
751
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
86
521
1.77
5.18
3.5
4.6
ug/l
18.0
30.5
0.31
74
432
(3014765) Yersinia sp identified in Stool by Organism specific culture
29
116
2.58
5.12
1.4
1.1
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
29
116
2.58
5.12
1.4
1.1
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
24
87
2.84
5.10
1.4
1.3
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
23
82
2.88
5.04
1.2
1.8
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
115
761
1.64
5.00
1.3
1.2
u/ml
3.7
1.3
0.42
27
194
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
13
32
4.13
4.92
1.7
1.8
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
29
119
2.51
4.87
1.4
1.1
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
22
78
2.89
4.87
1.2
1.1
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
11
24
4.65
4.80
1.2
1.8
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
11
24
4.65
4.80
1.2
1.8
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
11
24
4.65
4.80
1.8
2.1
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
11
24
4.65
4.80
1.0
1.3
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
11
24
4.65
4.80
1.2
1.8
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
37
171
2.24
4.80
2.4
2.0
—
—
—
0
0
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
16
48
3.40
4.63
1.0
1.1
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
7
5
14.15
4.58
1.6
1.0
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
221
1718
1.47
4.58
2.2
2.2
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
11
25
4.47
4.58
1.8
2.1
—
—
—
0
0
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
10
21
4.83
4.54
2.1
3.3
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
27
111
2.50
4.53
2.4
2.2
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
12
30
4.06
4.45
1.2
1.7
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
12
30
4.06
4.45
1.2
1.7
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
12
30
4.06
4.45
1.2
1.7
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
12
30
4.06
4.45
1.2
1.7
—
—
—
0
0
(44790047)
17
55
3.16
4.39
1.5
1.6
—
—
—
0
0
(44806118)
17
55
3.16
4.39
1.5
1.6
—
—
—
0
0
(44790049)
17
55
3.16
4.39
1.5
1.6
—
—
—
0
0
(44790048)
17
55
3.16
4.39
1.5
1.6
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
49
264
1.94
4.28
1.1
1.2
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
15
46
3.32
4.21
1.1
1.2
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
15
46
3.32
4.21
2.1
2.4
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
15
46
3.32
4.21
4.7
2.9
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
23
91
2.59
4.18
1.1
1.1
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
18
63
2.92
4.09
1.4
1.4
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
18
63
2.92
4.09
1.4
1.4
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
18
63
2.92
4.09
1.4
1.4
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
18
63
2.92
4.09
1.4
1.4
—
—
—
0
0
(3013727) Leukocytes other/100 leukocytes in Blood
8
10
8.09
4.07
1.8
5.2
%
43.8
46.2
—
8
10
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
21
81
2.65
4.01
1.2
1.1
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
18
64
2.87
3.99
1.4
1.4
—
—
—
0
0
(3030981) Hyaline casts [#/volume] in Urine by Automated count
48
264
1.89
3.96
3.5
2.6
e6/l
0.7
0.3
1.04
48
257
(3014051) Protein [Presence] in Urine by Test strip
20
76
2.69
3.94
2.6
2.7
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
14
43
3.31
3.93
1.1
1.4
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
16
54
3.02
3.87
1.1
1.1
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
16
54
3.02
3.87
2.8
2.9
—
—
—
0
0
(3015479) Mycobacterium sp identified in Blood by Organism specific culture
8
11
7.36
3.87
1.5
1.4
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
66
404
1.72
3.84
2.5
2.4
ug/g
156.9
151.8
0.04
57
320
(40768806) Pleura Pathology biopsy report
17
60
2.89
3.82
1.3
1.6
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
482
4423
1.58
3.82
5.3
4.7
mmol/l
6.2
6.0
1.14
447
3959
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
11
29
3.85
3.82
1.4
1.1
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
11
29
3.85
3.82
1.4
1.1
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
11
29
3.85
3.82
1.4
1.1
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
14
44
3.24
3.80
1.6
1.3
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
25
109
2.35
3.74
1.1
1.2
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
9
16
5.70
3.67
1.0
1.0
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
9
16
5.70
3.67
1.0
1.0
—
—
—
0
0
(40768446) Kidney Pathology biopsy report
9
16
5.70
3.67
2.1
1.4
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
11
30
3.72
3.65
1.4
1.1
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
11
30
3.72
3.65
1.4
1.1
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
11
30
3.72
3.65
1.4
1.1
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
17
62
2.80
3.62
1.5
1.4
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
34
172
2.04
3.57
1.4
1.3
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
35
180
2.01
3.51
1.5
1.6
—
—
—
0
0
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
8
13
6.22
3.51
1.1
1.3
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
45
254
1.84
3.45
6.7
3.0
e9/l
4.6
4.0
0.92
34
190
(3017817) Protein [Mass] in Urine collected for unspecified duration
13
42
3.14
3.39
2.1
2.8
—
—
—
0
0
(3042733) HLA Ab [Presence] in Serum
7
10
7.07
3.37
9.0
7.6
—
—
—
0
0
(3024980) IgG subclass 4 [Mass/volume] in Serum
17
65
2.67
3.33
1.4
1.8
g/l
0.9
0.9
0.01
12
48
(3019225) pH of Specimen
71
463
1.61
3.26
8.3
4.3
—
—
—
0
0
(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight
12
38
3.20
3.23
1.1
1.3
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
41
230
1.84
3.21
5.5
3.9
—
—
—
0
0
(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum
10
28
3.62
3.21
1.3
1.2
—
—
—
0
0
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
44
253
1.80
3.19
2.2
2.5
—
24.1
—
0
10
(3000093) Morphology [Interpretation] in Blood Narrative
12
39
3.12
3.10
1.0
1.1
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
12
39
3.12
3.10
1.3
1.4
—
—
—
0
0
(4015189)
7
12
5.89
3.03
1.4
2.1
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
60
384
1.63
2.98
8.3
3.5
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
8
17
4.76
2.93
1.8
1.3
—
—
—
0
0
(3033799) Differential panel - Peritoneal fluid
7
13
5.44
2.87
1.4
2.7
—
—
—
0
0
(3038071) Oxygen [Partial pressure] in Mixed venous blood
6
9
6.72
2.87
3.8
6.0
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
23
110
2.14
2.82
1.3
1.6
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
14
53
2.68
2.81
1.1
1.1
—
—
—
0
0
(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay
8
18
4.49
2.80
1.5
1.9
%
107.9
103.2
—
8
18
(21494755) Public health laboratory ask at order entry panel
13
309
0.41
2.77
1.2
1.4
—
—
—
0
0
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
25
125
2.05
2.75
2.1
2.5
ug/min
216.5
98.3
0.31
14
76
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
6
10
6.05
2.70
4.5
6.4
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
8
19
4.25
2.68
1.0
1.1
—
—
—
0
0
(40768443) Skin Pathology biopsy report
36
206
1.80
2.68
1.4
1.2
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
11
38
2.93
2.59
1.0
1.2
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
8
20
4.04
2.57
1.3
4.1
—
—
—
0
0
(40757373) Influenza virus identified in Isolate
5
7
7.19
2.55
1.4
1.4
—
—
—
0
0
(4035726)
64
435
1.53
2.49
1.6
1.4
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
477
4464
1.42
2.48
4.6
4.5
mmol/l
4.3
4.5
3.11
441
4076
(1761868) Lipid panel - Serum or Plasma
124
1571
0.73
2.47
3.2
2.9
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
8
205
0.38
2.47
1.5
1.3
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
12
45
2.70
2.46
1.1
1.2
—
—
—
0
0
(3022621) pH of Urine by Test strip
43
266
1.67
2.46
4.1
3.0
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
23
117
2.01
2.44
1.5
1.4
ug/g
238.3
285.8
0.50
13
66
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
38
228
1.71
2.43
1.2
1.4
—
72.3
—
0
13
(3017569) Oxygen content in Arterial blood
9
27
3.37
2.40
2.7
4.3
—
—
—
0
0
(3024139) IgG subclass 3 [Mass/volume] in Serum
11
40
2.78
2.38
1.5
1.3
g/l
0.6
0.5
—
6
24
(3028192) IgG subclass 2 [Mass/volume] in Serum
11
40
2.78
2.38
1.5
1.3
g/l
3.5
2.7
—
6
24
(3027135) IgG subclass 1 [Mass/volume] in Serum
11
40
2.78
2.38
1.5
1.3
g/l
10.9
7.5
—
6
24
(4062490)
11
40
2.78
2.38
1.5
1.3
—
—
—
0
0
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
5
8
6.29
2.37
1.0
1.0
—
—
—
0
0
(3006653) Thiamine [Moles/volume] in Blood
8
22
3.67
2.37
1.3
1.3
nmol/l
147.6
135.0
—
8
22
(3047007) Chlamydophila sp Ab [Presence] in Serum
12
47
2.59
2.28
1.2
1.2
—
—
—
0
0
(3036071) Salmonella sp Ab [Titer] in Serum
6
13
4.65
2.27
1.0
1.1
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
15
310
0.47
2.27
2.1
1.7
—
—
—
0
0
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
5
9
5.59
2.21
1.0
1.0
—
—
—
0
0
(3014891) Appearance of Pleural fluid
5
9
5.59
2.21
1.4
1.6
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
10
36
2.81
2.21
3.8
2.9
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
12
48
2.53
2.20
1.0
1.3
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
15
67
2.27
2.19
1.1
1.1
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
8
24
3.37
2.18
1.0
1.1
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
8
24
3.37
2.18
1.0
1.1
—
—
—
0
0
(3035880) pH of Pleural fluid
9
30
3.03
2.15
1.0
1.2
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
10
37
2.73
2.11
1.2
1.1
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
243
2103
1.27
2.10
4.7
5.0
ug/l
2.2
2.7
0.89
215
1851
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
483
4562
1.38
2.09
5.3
5.0
mmol/l
2.5
2.7
3.28
444
4126
(3003694) ABO and Rh group [Type] in Blood
144
1166
1.31
2.08
1.4
1.3
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
9
31
2.93
2.08
1.2
1.1
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
17
83
2.08
2.03
1.3
1.4
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
456
4275
1.33
2.02
4.2
4.0
mmol/l
1.4
1.3
1.91
414
3841
(3049717) Cytology report of Urine Cyto stain
36
225
1.64
2.02
2.7
3.0
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
10
38
2.66
2.02
1.4
1.8
—
—
—
0
0
(3011412) CD3 cells [#/volume] in Blood
10
38
2.66
2.02
1.4
1.8
e9/l
1.3
1.2
—
5
21
(3013512) EKG study
173
1442
1.29
2.01
6.5
4.0
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
470
4433
1.34
1.94
4.5
4.4
mmol/l
1.3
1.4
3.60
429
4013
(3023410) Appearance of Cerebral spinal fluid
11
45
2.47
1.94
1.3
1.4
—
—
—
0
0
(3028772) Osteocalcin [Mass/volume] in Serum or Plasma
6
16
3.78
1.94
1.8
3.3
—
—
—
0
0
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
6
16
3.78
1.94
1.0
1.2
—
—
—
0
0
(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum
6
16
3.78
1.94
3.3
1.5
ug/l
95.5
59.1
—
6
16
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
31
191
1.66
1.85
1.6
1.6
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
10
40
2.53
1.84
1.2
1.1
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
23
130
1.80
1.84
1.6
1.6
—
—
—
0
0
(3024471) HLA-A [Type]
5
12
4.19
1.82
1.0
1.0
—
—
—
0
0
(3024932) HLA-DR beta [Type]
5
12
4.19
1.82
1.0
1.2
—
—
—
0
0
(3008536) Aspergillus sp Ab [Presence] in Serum
5
12
4.19
1.82
1.2
1.3
—
—
—
0
0
(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay
5
12
4.19
1.82
17.4
2.0
%
182.8
168.4
—
5
12
(3000012) Reticulocyte production index
7
24
2.94
1.72
1.4
2.5
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
15
75
2.03
1.71
5.1
2.5
—
—
—
0
0
(3011648) Oxygen content in Venous blood
10
42
2.41
1.68
1.7
1.6
%
8.5
10.6
—
10
42
(3044242) Glucose [Moles/volume] in Arterial blood
8
31
2.60
1.66
2.1
3.7
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
7
25
2.82
1.65
1.4
1.9
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
7
25
2.82
1.65
1.3
1.5
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
11
49
2.27
1.64
1.0
1.3
nmol/l
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
33
214
1.58
1.63
1.7
1.8
—
—
—
0
0
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
5
14
3.59
1.62
1.0
1.0
miu/ml
2056.2
1300.3
—
5
14
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
7
27
2.61
1.52
1.0
1.4
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
7
27
2.61
1.52
1.0
1.4
—
—
—
0
0
(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma
13
65
2.02
1.49
3.8
2.1
u/ml
4.3
67.5
0.51
13
60
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
8
170
0.46
1.48
1.1
1.0
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
12
59
2.06
1.44
2.1
2.4
—
—
—
0
0
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
6
22
2.74
1.44
3.0
2.6
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
6
22
2.74
1.44
1.0
1.1
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
33
222
1.52
1.42
2.7
2.5
—
—
—
0
0
(3004451) EKG impression Narrative
7
29
2.43
1.39
1.7
1.4
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
23
143
1.63
1.37
7.3
4.5
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
6
23
2.63
1.37
1.2
1.3
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
6
23
2.63
1.37
1.0
1.2
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
6
23
2.63
1.37
1.0
1.1
—
—
—
0
0
(3028433) Virus identified in Specimen by Culture
5
17
2.96
1.36
1.2
1.2
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
0
37
0.00
1.35
0.0
1.5
—
—
—
0
0
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
12
61
1.99
1.33
1.0
1.2
u/ml
2.0
4.8
—
5
23
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
16
91
1.78
1.30
1.6
1.9
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
10
48
2.10
1.28
1.6
1.8
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
65
505
1.32
1.28
1.3
1.4
—
—
—
0
0
(4024509)
9
44
2.06
1.27
1.2
1.3
—
—
—
0
0
(3010503) CD19 cells [#/volume] in Blood
6
25
2.41
1.24
1.7
1.6
e9/l
0.0
0.1
—
6
25
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
6
25
2.41
1.24
1.0
1.4
—
—
—
0
0
(3030136) 5-Hydroxyindoleacetate [Moles/volume] in Serum or Plasma
5
19
2.65
1.22
1.0
2.9
nmol/l
192.0
140.7
—
5
19
(3034274) Bile acid [Moles/volume] in Serum --fasting
5
19
2.65
1.22
2.0
1.8
umol/l
15.0
5.3
—
5
12
(1002224) Polysomnography panel
9
169
0.53
1.20
1.2
1.0
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
33
231
1.45
1.20
1.2
1.2
—
—
—
0
0
(3022145) Colonoscopy Study observation
62
485
1.31
1.17
1.6
1.3
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
10
50
2.02
1.17
1.1
1.1
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
0
35
0.00
1.15
0.0
1.4
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
0
35
0.00
1.15
0.0
1.4
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
0
35
0.00
1.15
0.0
1.4
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
0
35
0.00
1.15
0.0
1.4
—
—
—
0
0
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
5
20
2.51
1.15
1.2
1.3
—
—
—
0
0
(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum
0
36
0.00
1.14
0.0
1.2
—
10.4
—
0
11
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
8
40
2.01
1.12
1.0
1.0
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
5
21
2.39
1.09
1.0
1.1
—
—
—
0
0
(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal
8
41
1.96
1.09
1.4
1.1
nmol/l
1.8
1.5
—
8
35
(3002256) Pathology report gross observation
72
583
1.27
1.07
1.3
1.3
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
9
46
1.97
1.04
1.1
1.2
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
14
83
1.70
1.02
2.1
1.3
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
9
48
1.89
1.01
1.1
1.1
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
0
30
0.00
0.97
0.0
1.4
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
0
30
0.00
0.97
0.0
1.4
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
10
54
1.87
0.97
1.0
1.3
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
0
31
0.00
0.96
0.0
1.5
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
16
102
1.59
0.91
1.3
1.3
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
12
71
1.70
0.89
1.7
2.0
—
—
—
0
0
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
8
45
1.79
0.84
1.0
1.1
—
—
—
0
0
(3014702) Chromogranin A [Moles/volume] in Serum or Plasma
8
45
1.79
0.84
1.4
2.6
nmol/l
5.0
3.6
—
8
45
(3000492) Spirometry study
48
382
1.28
0.84
1.3
1.5
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
6
32
1.88
0.82
1.0
1.2
—
—
—
0
0
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
0
25
0.00
0.79
0.0
1.0
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
5
24
2.09
0.74
1.0
1.1
—
—
—
0
0
(4034850)
20
142
1.42
0.73
11.0
8.4
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
5
25
2.01
0.73
5.2
2.3
—
—
—
0
0
(3005570) Glucose [Moles/volume] in Urine
9
58
1.56
0.70
1.7
1.8
—
—
—
0
0
(4146454)
9
59
1.53
0.68
1.8
2.7
—
—
—
0
0
(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay
5
28
1.79
0.66
1.2
1.5
u/l
51.8
22.6
—
5
21
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
182
1683
1.12
0.60
3.7
4.2
%
22.8
21.6
0.43
96
867
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
5
87
0.57
0.56
1.0
1.5
—
—
—
0
0
(4281824)
6
37
1.63
0.55
1.0
1.1
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
6
37
1.63
0.55
1.2
1.2
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
9
62
1.46
0.53
1.4
1.6
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
11
156
0.70
0.50
1.7
1.7
—
—
—
0
0
(3017446) Testosterone [Moles/volume] in Serum or Plasma
44
373
1.19
0.49
2.2
2.1
nmol/l
13.6
12.9
0.17
37
339
(21494434) Karyotype in Bone marrow
7
48
1.46
0.47
1.4
1.2
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
131
1208
1.11
0.46
1.6
1.6
mmol/l
1.4
1.4
0.14
109
976
(4094501)
8
120
0.66
0.46
1.1
1.1
—
—
—
0
0
(3021387) Prolactin [Units/volume] in Serum or Plasma
11
77
1.44
0.46
1.2
1.8
mu/l
329.2
321.6
0.04
11
72
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
63
556
1.15
0.44
18.3
6.6
—
—
—
0
0
(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma
19
149
1.28
0.42
2.6
2.5
u/ml
40.1
90.0
0.75
19
144
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
0
15
0.00
0.41
0.0
1.8
—
—
—
0
0
(3020650) Glucose [Presence] in Urine
0
16
0.00
0.41
0.0
1.0
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
0
17
0.00
0.40
0.0
1.5
—
—
—
0
0
(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma
9
67
1.35
0.38
2.3
2.5
u/ml
19.7
24.8
—
9
67
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
47
415
1.14
0.35
1.6
1.6
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
11
140
0.78
0.28
1.2
1.2
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
55
601
0.91
0.26
5.2
4.6
%
35.7
31.9
1.45
45
390
(4010399)
34
302
1.13
0.25
1.4
1.4
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
35
389
0.89
0.23
1.3
1.4
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
130
1241
1.06
0.22
3.0
3.0
ug/l
0.7
0.8
0.89
94
857
(4268621)
5
42
1.19
0.21
1.6
2.2
—
—
—
0
0
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(3001186) Copper [Moles/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
1.1
—
16.2
—
0
10
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid
0
12
0.00
0.21
0.0
1.1
—
20.3
—
0
6
(3003740) Influenza virus B Ag [Presence] in Specimen
6
53
1.13
0.18
1.7
1.1
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
6
53
1.13
0.18
1.7
1.1
—
—
—
0
0
(4306422)
7
59
1.19
0.18
1.0
1.2
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
7
61
1.15
0.17
1.0
1.1
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
7
63
1.11
0.17
1.1
1.0
—
—
—
0
0
(40768793) Breast Pathology biopsy report
7
88
0.79
0.14
1.6
1.3
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
23
209
1.10
0.13
1.1
1.2
iu/ml
104.9
154.4
—
10
83
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
24
259
0.92
0.10
1.4
1.4
—
—
—
0
0
(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation
10
92
1.09
0.03
2.3
1.6
pmol/l
241.3
234.1
—
10
84
(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma
12
124
0.97
0.00
2.3
1.6
nmol/l
46.4
40.4
0.48
12
118
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
13
128
1.02
0.00
1.6
1.6
—
—
—
0
0
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay
0
8
0.00
0.00
0.0
1.0
—
23.5
—
0
8
(40765089) Chromosome analysis panel - Blood by G-banded
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
6
62
0.97
0.00
1.3
1.4
—
—
—
0
0
(21491866) Provasopressin.C-terminal [Moles/volume] in Serum or Plasma by Immunoassay
0
5
0.00
0.00
0.0
1.0
—
21.9
—
0
5
(40758355) Pancreatic polypeptide [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
4.3
—
104.8
—
0
6
(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3016330) Potassium [Moles/time] in 24 hour Urine
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3013247) Albumin in CSF/Albumin in Serum or Plasma
0
7
0.00
0.00
0.0
1.0
—
6.6
—
0
7
(3032743) Legionella sp IgG Ab [Presence] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(21494567) Legionella sp IgM Ab [Presence] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3047166) Epithelial cells [#/area] in Urine sediment by Automated count
0
7
0.00
0.00
0.0
3.6
—
0.4
—
0
7
(3007916) DNA double strand Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3051101) Glucose [Moles/volume] in Cord blood
0
8
0.00
0.00
0.0
4.9
—
—
—
0
0
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis
0
8
0.00
0.00
0.0
5.0
—
—
—
0
0
(3017115) Methotrexate [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
6.6
—
0.3
—
0
5
(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3032868) Hemoglobin electrophoresis panel in Blood
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(3050794) Legionella sp Ab [Presence] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint M13_DISCITIS and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| M13_DISCITIS | 2.337 [1.84, 2.97] | < 0.001 |
| Birth year | 0.997 [0.99, 1.01] | 0.524 |
During the follow-up period (1.1.1998 — 31.12.2019), 358 out of 1285 females with M13_DISCITIS died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| M13_DISCITIS | 2.407 [1.94, 2.98] | < 0.001 |
| Birth year | 0.986 [0.98, 1.0] | 0.004 |
During the follow-up period (1.1.1998 — 31.12.2019), 569 out of 1892 males with M13_DISCITIS died.
Mortality risk
Mortality risk for people of age
years, who have M13_DISCITIS.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.203% | 0.437% |
| 5 | 1.306% | 2.524% |
| 10 | 3.654% | 6.535% |
| 15 | 7.338% | 12.408% |
| 20 | 12.465% | 20.51% |
Relationships between endpoints
↥Index endpoint: M13_DISCITIS – Discitis, unspecified
GWS hits: 1
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data